INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46m ago
House PTR5m ago
SEC 13F5m ago
Robinhood Chain5m ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.66B / 18S · 11 late84 trades$24.31M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

69,473 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PR
Puthenveetil RejiEVP, Additive Solutions & CCO
DDD3D SYSTEMS CORP
Tax withholding
F$23K
11.7K sh
Apr 14, 2026Apr 16, 2026
Page 958 of 1737
← PrevNext →
traded Apr 14, 2026
+2d
SEC Form 4

Evidence

9
HG
Hook Michelle GreigCFO & Treasurer
PTLOPortillo's Inc.
Tax withholding
F$22K
3,945 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
WA
Webster AaronEVP, Global Chief Risk Officer
PYPLPayPal Holdings, Inc.
Option exercise
M—
2,622 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
WV
Woolway Paul VMD, Chief Banking Officer
SCHWSCHWAB CHARLES CORP
Option exercise · 10b5-1 plan
M$413K
7,941 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
NB
Nordstrom Phyllis BEVP, CFO and CAO
DDD3D SYSTEMS CORP
Tax withholding
F$3,219
1,626 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

9
PM
Preston Jack MCHIEF FINANCIAL OFFICER
RHRH
Grant or award
A—
25.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

9
TC
Thornton Joseph ClayInterim CFO
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$8,482
4,158 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

9
HS
Haselden StuartCEO of Arc'teryx Equipment
ASAmer Sports, Inc.
Option exercise
M—
21.3K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,250 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M—
9,215 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M—
10.7K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

7
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
2,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$67K
5,604 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

6
HT
Holme TimothyCHIEF TECHNOLOGY OFFICER
QSQuantumScape Corp
Grant or award
A—
109.8K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

6
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$141K
12.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
PK
Pilkington KyleCHIEF LEGAL OFFICER
SESSES AI Corp
Tax withholding
F$28K
25.2K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
HK
Hettrich KevinCHIEF FINANCIAL OFFICER
QSQuantumScape Corp
Grant or award
A—
86.1K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
RL
Reynoso Jamie L.CEO, Medicare Advantage
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$26K
12.7K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
PP
Priest Brady PatrickCEO of Clover Care Services
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
Tax withholding
F$32K
15.5K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
PJ
Peil A JosephExecutive VP and CIO
EPRTESSENTIAL PROPERTIES REALTY TRUST, INC.
Grant or award
A—
165 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
GH
Gan HongCHIEF SCIENCE OFFICER
SESSES AI Corp
Tax withholding
F$35K
32.1K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

5
MM
Murphy Scott MChief Accounting Officer
RPDRapid7, Inc.
Tax withholding
F$1,981
344 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Option exercise
M—
1,322 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

5
YS
Yates Daniel S.SVP, Chief Accounting Officer
DTDynatrace, Inc.
Tax withholding
F$14K
393 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

4
HA
Haas Rene A.Director, Chief Executive Officer
ARMARM HOLDINGS PLC /UK
Open-market sale · 10b5-1 plan
SELL$907K
5,646 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

4
HA
Haas Rene A.Director, Chief Executive Officer
ARMARM HOLDINGS PLC /UK
Open-market sale · 10b5-1 plan
SELL$561K
3,483 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

3
CD
Chairman DavidSVP, R&D
VLNValens Semiconductor Ltd.
Option exercise · 10b5-1 plan
M—
5,616 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

3
RR
Remer Eric RichardDirector, Chief Executive Officer
EVCMEverCommerce Inc.
Open-market sale · 10b5-1 plan
SELL$19K
1,596 sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$92K
9,215 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$56K
6,250 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$124K
11.0K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$56K
2,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
CS
Calvin SandraSVP, CHIEF ACCOUNTING OFFICER
TVTXTravere Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$133K
6,500 sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

2
MS
Manko SteveCFO
SKYTSkyWater Technology, Inc
Option exercise · 10b5-1 plan
M$126K
10.7K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC Form 4

Evidence

1
CD
Cassens Michael DavidDirector
BUSEFIRST BUSEY CORP /NV/
Open-market sale · 10b5-1 plan
SELL$20K
750 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

1
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

1
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence

1
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Open-market sale · 10b5-1 plan
SELL$9,840
116 sh
Apr 16, 2026Apr 16, 2026
traded Apr 16, 2026
+0dSEC Form 4

Evidence

0
TM
Tariq MusaDirector
GHGuardant Health, Inc.
Option exercise · 10b5-1 plan
M—
250 sh
Apr 15, 2026Apr 16, 2026
traded Apr 15, 2026
+1dSEC Form 4

Evidence